Literature DB >> 31636130

Sensitivity of chest X-ray for detecting lung cancer in people presenting with symptoms: a systematic review.

Stephen H Bradley1, Sarah Abraham2, Matthew Ej Callister3, Adam Grice1, William T Hamilton4, Rocio Rodriguez Lopez5, Bethany Shinkins5, Richard D Neal1.   

Abstract

BACKGROUND: Despite increasing use of computed tomography (CT), chest X-ray remains the first-line investigation for suspected lung cancer in primary care in the UK. No systematic review evidence exists as to the sensitivity of chest X-ray for detecting lung cancer in people presenting with symptoms. AIM: To estimate the sensitivity of chest X-ray for detecting lung cancer in symptomatic people. DESIGN AND
SETTING: A systematic review was conducted to determine the sensitivity of chest X-ray for the detection of lung cancer.
METHOD: Databases including MEDLINE, EMBASE, and the Cochrane Library were searched; a grey literature search was also performed.
RESULTS: A total of 21 studies met the eligibility criteria. Almost all were of poor quality. Only one study had the diagnostic accuracy of chest X-ray as its primary objective. Most articles were case studies with a high risk of bias. Several were drawn from non-representative groups, for example, specific presentations, histological subtypes, or comorbidities. Only three studies had a low risk of bias. Two primary care studies reported sensitivities of 76.8% (95% confidence interval [CI] = 64.5 to 84.2%) and 79.3% (95% CI = 67.6 to 91.0%). One secondary care study reported a sensitivity of 79.7% (95% CI = 72.7 to 86.8%).
CONCLUSION: Though there is a paucity of evidence, the highest-quality studies suggest that the sensitivity of chest X-ray for symptomatic lung cancer is only 77% to 80%. GPs should consider if further investigation is necessary in high-risk patients who have had a negative chest X-ray. © British Journal of General Practice 2019.

Entities:  

Keywords:  X-rays; diagnostic imaging; early diagnosis; lung cancer; primary care

Mesh:

Year:  2019        PMID: 31636130      PMCID: PMC6805164          DOI: 10.3399/bjgp19X706853

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  38 in total

Review 1.  The expanding role of primary care in cancer control.

Authors:  Greg Rubin; Annette Berendsen; S Michael Crawford; Rachel Dommett; Craig Earle; Jon Emery; Tom Fahey; Luigi Grassi; Eva Grunfeld; Sumit Gupta; Willie Hamilton; Sara Hiom; David Hunter; Georgios Lyratzopoulos; Una Macleod; Robert Mason; Geoffrey Mitchell; Richard D Neal; Michael Peake; Martin Roland; Bohumil Seifert; Jeff Sisler; Jonathan Sussman; Stephen Taplin; Peter Vedsted; Teja Voruganti; Fiona Walter; Jane Wardle; Eila Watson; David Weller; Richard Wender; Jeremy Whelan; James Whitlock; Clare Wilkinson; Niek de Wit; Camilla Zimmermann
Journal:  Lancet Oncol       Date:  2015-09       Impact factor: 41.316

2.  Negative chest X-rays in primary care patients with lung cancer.

Authors:  Sally Stapley; Deborah Sharp; William Hamilton
Journal:  Br J Gen Pract       Date:  2006-08       Impact factor: 5.386

3.  Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: implications for patient care.

Authors:  Malcolm V Brock; Craig M Hooker; Eric A Engels; Richard D Moore; Maura L Gillison; Anthony J Alberg; Jeanne C Keruly; Stephen C Yang; Richard F Heitmiller; Stephen B Baylin; James G Herman; Julie R Brahmer
Journal:  J Acquir Immune Defic Syndr       Date:  2006-09       Impact factor: 3.731

4.  A prospective evaluation of hemoptysis cases in a tertiary referral hospital.

Authors:  Oğuz Uzun; Yildiz Atasoy; Serhat Findik; Atilla Güven Atici; Levent Erkan
Journal:  Clin Respir J       Date:  2010-07       Impact factor: 2.570

5.  Delay in diagnosis of lung cancer in general practice.

Authors:  Marianne Bjerager; Torben Palshof; Ronald Dahl; Peter Vedsted; Frede Olesen
Journal:  Br J Gen Pract       Date:  2006-11       Impact factor: 5.386

6.  Novel effects of gefitinib on mucin production in bronchioloalveolar carcinoma; two case reports.

Authors:  Takeshi Kitazaki; Masaaki Fukuda; Hiroshi Soda; Shigeru Kohno
Journal:  Lung Cancer       Date:  2005-07       Impact factor: 5.705

7.  [Metastatic cáncer presentation. Validation of a diagnostic algorithm with 221 consecutive patients].

Authors:  F Losa Gaspà; J R Germá; J M Albareda; A Fernández-Ortega; S Sanjosé; V Fernández Trigo
Journal:  Rev Clin Esp       Date:  2002-06       Impact factor: 1.556

8.  Estimation of mean sojourn time for lung cancer by chest X-ray screening with a Bayesian approach.

Authors:  Chun-Ru Chien; Mei-Shu Lai; Tony Hsiu-Hsi Chen
Journal:  Lung Cancer       Date:  2008-04-09       Impact factor: 5.705

9.  Missed non-small cell lung cancer: radiographic findings of potentially resectable lesions evident only in retrospect.

Authors:  Priya Kumar Shah; John H M Austin; Charles S White; Pavni Patel; Linda B Haramati; Gregory D N Pearson; Maria C Shiau; Yahya M Berkmen
Journal:  Radiology       Date:  2003-01       Impact factor: 11.105

10.  QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.

Authors:  Penny F Whiting; Anne W S Rutjes; Marie E Westwood; Susan Mallett; Jonathan J Deeks; Johannes B Reitsma; Mariska M G Leeflang; Jonathan A C Sterne; Patrick M M Bossuyt
Journal:  Ann Intern Med       Date:  2011-10-18       Impact factor: 25.391

View more
  12 in total

Review 1.  Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality.

Authors:  Asha Bonney; Reem Malouf; Corynne Marchal; David Manners; Kwun M Fong; Henry M Marshall; Louis B Irving; Renée Manser
Journal:  Cochrane Database Syst Rev       Date:  2022-08-03

2.  The diagnostic performance of chest radiographs for lung malignancy in symptomatic primary-care populations: A systematic review and meta-analysis.

Authors:  Louis Dwyer-Hemmings; Cassandra Fairhead
Journal:  BJR Open       Date:  2021-07-29

3.  Computed tomography perfusion (CTP) in primary lung cancer: Results from a tertiary care centre.

Authors:  Mufeed Arimbrakkunnan; Pawan K Garg; Pushpinder S Khera; Binit Sureka; Poonam Elhence; Puneet Pareek; Nishant Kumar Chauhan; Taruna Yadav
Journal:  Lung India       Date:  2022 May-Jun

4.  Estimating lung cancer risk from chest X-ray and symptoms: a prospective cohort study.

Authors:  Stephen H Bradley; Nathaniel Luke Fielding Hatton; Rehima Aslam; Bobby Bhartia; Matthew Ej Callister; Martyn Pt Kennedy; Luke Ta Mounce; Bethany Shinkins; William T Hamilton; Richard D Neal
Journal:  Br J Gen Pract       Date:  2021-03-26       Impact factor: 5.386

5.  Lung cancer risk following previous abnormal chest radiographs: A 27-year follow-up study of a Chinese lung screening cohort.

Authors:  Yaguang Fan; Zheng Su; Mengna Wei; Hao Liang; Yong Jiang; Xuebing Li; Zhaowei Meng; Ying Wang; Heng Wu; Jinzhao Song; Youlin Qiao; Qinghua Zhou
Journal:  Thorac Cancer       Date:  2021-11-09       Impact factor: 3.500

6.  Deep Mining Generation of Lung Cancer Malignancy Models from Chest X-ray Images.

Authors:  Michael Horry; Subrata Chakraborty; Biswajeet Pradhan; Manoranjan Paul; Douglas Gomes; Anwaar Ul-Haq; Abdullah Alamri
Journal:  Sensors (Basel)       Date:  2021-10-07       Impact factor: 3.576

7.  Increased use of diagnostic CT imaging increases the detection of stage IA lung cancer: pathways and patient characteristics.

Authors:  Charlotte Hyldgaard; Christian Trolle; Stefan Markus Walbom Harders; Henriette Engberg; Torben Riis Rasmussen; Henrik Møller
Journal:  BMC Cancer       Date:  2022-04-27       Impact factor: 4.638

Review 8.  Exhaled Aldehydes as Biomarkers for Lung Diseases: A Narrative Review.

Authors:  Maximilian Alexander Floss; Tobias Fink; Felix Maurer; Thomas Volk; Sascha Kreuer; Lukas Martin Müller-Wirtz
Journal:  Molecules       Date:  2022-08-17       Impact factor: 4.927

9.  Primary Care System Factors and Clinical Decision-making in Patients that Could Have Lung Cancer: a Vignette Study in Five Balkan Region Countries.

Authors:  Davorina Petek; Radost Assenova; Gergana Foreva; Svjetlana Gašparović Babić; Marija Petek Šter; Nuša Prebil; Aida Puia; Emmanouil Smyrnakis; Michael Harris
Journal:  Zdr Varst       Date:  2021-12-27

10.  Diagnostic and prognostic value of microRNA-2355-3p and contribution to the progression in lung adenocarcinoma.

Authors:  Yanan Zhao; Wenlong Zhang; Yang Yang; Enyong Dai; Yuansong Bai
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.